written on 23.06.2014

Some cancer docs still bill heavily for Amgen's Epogen despite safety questions


Many cancer doctors have cut back on their use of Amgen&#39;s anemia drug Epogen–also sold as Procrit by Johnson &amp; Johnson–because of safety questions that arose over the past few years. But as <em>The Wall Street Journal </em>reports, one Florida doctors&#39; group still administers the drug in quantity, accounting for one-sixth of related Medicare charges in 2012.